Neutral
PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20%
PROCEPT BioRobotics reported a 20% increase in Q1 2026 revenue to $83.1 million, driven by higher system sales, consumables, and services, especially ...
PRCT
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest PRCT News
Research PRCT on:
Ad Space